Bulk Manufacturer of Controlled Substances Registration, 25334-25335 [2017-11383]
Download as PDF
<![CDATA[
25334
Federal Register / Vol. 82, No. 104 / Thursday, June 1, 2017 / Notices
violation of subsection (a)(1)(B) of
section 337 in the importation into the
United States, the sale for importation,
or the sale within the United States after
importation of certain magnetic tape
cartridges and components thereof by
reason of infringement of one or more of
claims 1–19 of the ’596 patent; claims
1–6 and 8 of the ’501 patent; and claims
1–11 and 15–20 of the ’774 patent, and
whether an industry in the United
States exists as required by subsection
(a)(2) of section 337;
(2) Pursuant to Commission Rule
210.50(b)(1), 19 CFR 210.50(b)(1), the
presiding administrative law judge shall
take evidence or other information and
hear arguments from the parties and
other interested persons with respect to
the public interest in this investigation,
as appropriate, and provide the
Commission with findings of fact and a
recommended determination on this
issue, which shall be limited to the
statutory public interest factors set forth
in 19 U.S.C. 1337(d)(1), (f)(1), (g)(1);
(3) For the purpose of the
investigation so instituted, the following
are hereby named as parties upon which
this notice of investigation shall be
served:
(a) The complainants are:
Sony Corporation, 1–7–1 Konan,
Minato-ku, Tokyo 108–0075, Japan.
Sony Storage Media Solutions
Corporation, 1–7–1 Konan, Minato-ku,
Tokyo 108–0075, Japan.
Sony Storage Media Manufacturing
Corporation, 3–4–1 Sakuragi, Tagajo,
Miyagi 985–0842, Japan.
Sony DADC US Inc., 1800 North
Fruitridge Avenue, Terre Haute, IN
47804.
Sony Latin America Inc., 5201 Blue
Lagoon Drive, Suite 400, Miami, FL
33126.
(b) The respondents are the following
entities alleged to be in violation of
section 337, and are the parties upon
which the complaint is to be served:
Fujifilm Holdings Corporation, 7–3
Akasaka 9-chome, Minato-ku, Tokyo
107–0052, Japan.
Fujifilm Corporation, 7–3 Akasaka 9chome, Minato-ku, Tokyo 107–0052,
Japan.
Fujifilm Media Manufacturing Co.,
Ltd., 12–1 Ogimachi 2-chome, Odawara,
Kanagawa 250–0001, Japan.
Fujifilm Holdings America
Corporation, 200 Summit Lake Drive,
Valhalla, NY 10595.
Fujifilm Recording Media U.S.A., Inc.,
45 Crosby Drive, Bedford, MA 01730–
1401.
(c) The Office of Unfair Import
Investigations, U.S. International Trade
Commission, 500 E Street SW., Suite
401, Washington, DC 20436; and
(4) For the investigation so instituted,
the Chief Administrative Law Judge,
U.S. International Trade Commission,
shall designate the presiding
Administrative Law Judge.
Responses to the complaint and the
notice of investigation must be
submitted by the named respondents in
accordance with section 210.13 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(e) and 210.13(a), such
responses will be considered by the
Commission if received not later than 20
days after the date of service by the
Commission of the complaint and the
notice of investigation. Extensions of
time for submitting responses to the
complaint and the notice of
investigation will not be granted unless
good cause therefor is shown.
Failure of a respondent to file a timely
response to each allegation in the
complaint and in this notice may be
deemed to constitute a waiver of the
right to appear and contest the
allegations of the complaint and this
notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the complaint and this notice
and to enter an initial determination
and a final determination containing
such findings, and may result in the
issuance of an exclusion order or a cease
and desist order or both directed against
the respondent.
By order of the Commission.
Issued: May 26, 2017.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2017–11307 Filed 5–31–17; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Registration
ACTION:
Registrants listed below have
applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as bulk
manufacturers of various classes of
controlled substances.
SUPPLEMENTARY INFORMATION: The
companies listed below applied to be
registered as manufacturers of various
basic classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
for these notices.
SUMMARY:
Company
FR docket
mstockstill on DSK30JT082PROD with NOTICES
Cody Laboratories, Inc ...................................................................................................................................
Alcami Wisconsin Corporation .......................................................................................................................
Johnson Matthey, Inc .....................................................................................................................................
Noramco, Inc ..................................................................................................................................................
Organix, Inc ....................................................................................................................................................
Mallinckrodt, LLC ...........................................................................................................................................
Siemens Healthcare Diagnostics, Inc ............................................................................................................
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of these registrants to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
VerDate Sep<11>2014
21:19 May 31, 2017
Jkt 241001
investigated each of the company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
PO 00000
Frm 00111
Notice of registration.
Fmt 4703
Sfmt 4703
81
81
81
82
82
82
82
FR
FR
FR
FR
FR
FR
FR
61249
63219
71767
6645
8433
13136
13506
Published
September 6, 2016.
September 14, 2016.
October 18, 2016.
January 19, 2017.
January 25, 2017.
March 9, 2017.
March 13, 2017.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
registration as a bulk manufacturer to
the above listed companies.
E:\FR\FM\01JNN1.SGM
01JNN1
25335
Federal Register / Vol. 82, No. 104 / Thursday, June 1, 2017 / Notices
Dated: May 23, 2017.
Louis J. Milione,
Assistant Administrator.
The company plans to manufacture
small quantities of the listed controlled
substance in bulk for distribution to its
customers.
[FR Doc. 2017–11383 Filed 5–31–17; 8:45 am]
Dated: May 23, 2017.
Louis J. Milione,
Assistant Administrator.
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[FR Doc. 2017–11385 Filed 5–31–17; 8:45 am]
BILLING CODE 4410–09–P
Drug Enforcement Administration
[Docket No. DEA–392]
DEPARTMENT OF JUSTICE
Bulk Manufacturer of Controlled
Substances Application: Chemtos,
LLC
ACTION:
Drug Enforcement Administration
[Docket No. DEA–392]
Notice of application.
Registered bulk manufacturers of
the affected basic class, and applicants
therefore, may file written comments on
or objections to the issuance of the
proposed registration in accordance
with 21 CFR 1301.33(a) on or before July
31, 2017.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on July 5,
2016, Chemtos, LLC, 14101 W. Highway
290, Building 2000B, Austin, Texas
78737–9331 applied to be registered as
a bulk manufacturer for 3,4Methylenedioxymethamphetamine
(7405), a basic class of controlled
substance listed in schedule I.
mstockstill on DSK30JT082PROD with NOTICES
SUPPLEMENTARY INFORMATION:
Importer of Controlled Substances
Application: Cerilliant Corporation
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before July 3, 2017]. Such persons
may also file a written request for a
hearing on the application pursuant to
21 CFR 1301.43 on or before July 3,
2017.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
DATES:
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on April
6, 2017, Cerilliant Corporation, 811
Paloma Drive, Suite A, Round Rock,
Texas 78665–2402 applied to be
registered as an importer of U–47700
(3,4-dichloro-N-[2dimethylamino)cyclohexyl]-Nmethylbenzamide) (9547), a basic class
of controlled substance listed in
schedule I.
The company plans to import small
quantities of the listed controlled
substance for the manufacture of
analytical reference standards and
distribution to their research and
forensic customers.
Dated: May 25, 2017.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017–11387 Filed 5–31–17; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
ACTION:
Registrants listed below have
applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as importers of
various classes of schedule I or II
controlled substances.
SUPPLEMENTARY INFORMATION: The
companies listed below applied to be
registered as importers of various basic
classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for these notices.
SUMMARY:
Company
FR docket
Chattem Chemicals, Inc .................................................................................................................................
Anderson Brecon, Inc ....................................................................................................................................
Hospira ...........................................................................................................................................................
Myoderm ........................................................................................................................................................
Meridian Medical Technologies .....................................................................................................................
VerDate Sep<11>2014
18:32 May 31, 2017
Jkt 241001
PO 00000
Frm 00112
Notice of registration.
Fmt 4703
Sfmt 4703
E:\FR\FM\01JNN1.SGM
81
81
82
82
82
FR
FR
FR
FR
FR
01JNN1
62177
71766
11241
13134
13135
Published
September 8, 2016.
October 18, 2016.
February 21, 2017.
March 9, 2017.
March 9, 2017.
]]>Agencies
[Federal Register Volume 82, Number 104 (Thursday, June 1, 2017)]
[Notices]
[Pages 25334-25335]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-11383]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Registrants listed below have applied for and been granted
registration by the Drug Enforcement Administration (DEA) as bulk
manufacturers of various classes of controlled substances.
SUPPLEMENTARY INFORMATION: The companies listed below applied to be
registered as manufacturers of various basic classes of controlled
substances. Information on previously published notices is listed in
the table below. No comments or objections were submitted for these
notices.
----------------------------------------------------------------------------------------------------------------
Company FR docket Published
----------------------------------------------------------------------------------------------------------------
Cody Laboratories, Inc................... 81 FR 61249 September 6, 2016.
Alcami Wisconsin Corporation............. 81 FR 63219 September 14, 2016.
Johnson Matthey, Inc..................... 81 FR 71767 October 18, 2016.
Noramco, Inc............................. 82 FR 6645 January 19, 2017.
Organix, Inc............................. 82 FR 8433 January 25, 2017.
Mallinckrodt, LLC........................ 82 FR 13136 March 9, 2017.
Siemens Healthcare Diagnostics, Inc...... 82 FR 13506 March 13, 2017.
----------------------------------------------------------------------------------------------------------------
The DEA has considered the factors in 21 U.S.C. 823(a) and
determined that the registration of these registrants to manufacture
the applicable basic classes of controlled substances is consistent
with the public interest and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971. The DEA investigated each of the company's maintenance of
effective controls against diversion by inspecting and testing each
company's physical security systems, verifying each company's
compliance with state and local laws, and reviewing each company's
background and history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the DEA has granted a registration as a bulk manufacturer
to the above listed companies.
[[Page 25335]]
Dated: May 23, 2017.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017-11383 Filed 5-31-17; 8:45 am]
BILLING CODE 4410-09-P
